Recent Issues of Bentham Science Journals have been Published

Inflammation & Allergy-Drug Targets, 13 Issue 4

Aims & scope

Inflammation & #Allergy – Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in inflammation and allergy e.g. disease specific proteins, receptors, enzymes, genes. The journal publishes expert in-depth reviews, original research articles, drug clinical trial studies and guest edited thematic issues covering a range of current topics on drug targets involved in inflammation and allergy. As the discovery, identification, characterization and validation of novel human drug targets for anti-inflammation and allergy drug discovery continue to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

http://www.eurekaselect.com/124592/issue/4

Abstracted & Indexed in

Chemical Abstracts, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, MEDLINE/Index Medicus, EMBASE/ExcerptaMedica, Scopus, PubsHub, GenamicsJournalSeek, MediaFinder®-Standard Periodical Directory, and J-Gate..

For details about the latest issues, visit:http://benthamscience.com/journal/index.php?journalID=iadt

 

Current Topics in Medicinal Chemistry, 14 Issue 14

Aims & scope

Current Topics in Medicinal Chemistry is a forum for the review of areas of keen and topical interest to medicinal chemists and others in the allied disciplines. Each issue is solely devoted to a specific topic, containing six to nine reviews, which provide the reader a comprehensive survey of that area. A Guest Editor who is an expert in the topic under review, will assemble each issue. The scope of Current Topics in Medicinal Chemistry will cover all areas of medicinal chemistry, including current developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, compound diversity measurements, drug absorption, drug distribution, metabolism, new and emerging drug targets, natural products, pharmacogenomics, and structure-activity relationships. Medicinal chemistry is a rapidly maturing discipline. The study of how structure and function are related is absolutely essential to understanding the molecular basis of life. Current Topics in Medicinal Chemistry aims to contribute to the growth of scientific knowledge and insight, and facilitate the discovery and development of new therapeutic agents to treat debilitating human disorders. The journal is essential for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important advances.

http://www.eurekaselect.com/124602/issue/14

Abstracted & Indexed in

BIOSIS, Chemical Abstracts, MEDLINE/Index Medicus, PUBMED, ISI, Science Citation Index ExpandedTM, Biochemistry & Biophysics Citation IndexTM, index to Scientific Reviews®, Current Contents®, EMBASE/ExcerptaMedica, Journal Citation Reports/Science Edition, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Scopus, GenamicsJournalSeek, MediaFinder®-Standard Periodical Directory, PubsHub, and J-Gate.

For details about the latest issues, visit:http://benthamscience.com/journal/index.php?journalID=ctmc

 

Mini-Reviews in Organic Chemistry, 11 Issue 3

Aims & scope

Current Topics in Medicinal Chemistry is a forum for the review of areas of keen and topical interest to medicinal chemists and others in the allied disciplines. Each issue is solely devoted to a specific topic, containing six to nine reviews, which provide the reader a comprehensive survey of that area. A Guest Editor who is an expert in the topic under review, will assemble each issue. The scope of Current Topics in Medicinal Chemistry will cover all areas of medicinal chemistry, including current developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, compound diversity measurements, drug absorption, drug distribution, metabolism, new and emerging drug targets, natural products, pharmacogenomics, and structure-activity relationships. Medicinal chemistry is a rapidly maturing discipline. The study of how structure and function are related is absolutely essential to understanding the molecular basis of life. Current Topics in Medicinal Chemistry aims to contribute to the growth of scientific knowledge and insight, and facilitate the discovery and development of new therapeutic agents to treat debilitating human disorders. The journal is essential for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important advances.

http://www.eurekaselect.com/124555/issue/3

Abstracted & Indexed in

BIOSIS, Chemical Abstracts, MEDLINE/Index Medicus, PUBMED, ISI, Science Citation Index ExpandedTM, Biochemistry & Biophysics Citation IndexTM, index to Scientific Reviews®, Current Contents®, EMBASE/ExcerptaMedica, Journal Citation Reports/Science Edition, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Scopus, GenamicsJournalSeek, MediaFinder®-Standard Periodical Directory, PubsHub, and J-Gate

For details about the latest issues, visit:http://benthamscience.com/journal/index.php?journalID=ctmc

 

Current Inorganic Chemistry, 4 Issue 2

Aims & scope

Current Inorganic #Chemistry, a peer-reviewed journal, publishing original research, review articles and guest edited thematic issues in all areas of inorganic chemistry. The journal’s scope includes the synthesis, crystal structure, physical methods, thermodynamics, reactivity, spectroscopy, electronic and bonding properties of significant new and known (bio) inorganic and organometallic compounds.

Current Inorganic Chemistry is an important and reliable source of information on current developments, research and theory in the field. The emphasis is on publishing high quality articles.

http://www.eurekaselect.com/124573/issue/2

Abstracted & Indexed in

Chemical Abstracts, MediaFinder®-Standard Periodical Directory, and J-Gate.

For details about the latest issues, visit: http://benthamscience.com/journal/index.php?journalID=cic

 

Current Drug Targets, 15 Issue 10

Aims & scope

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.

Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication mini- & full-length review articles and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

http://www.eurekaselect.com/124609/issue/10

Abstracted & Indexed in

#ChemicalAbstracts, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Science Citation Index Expanded® (Sci Search), Index to Scientific Reviews®, Biochemistry & Biophysics Citation Index®, PUBMED, BIOSIS, Journal Citation Reports/Science Edition, EMBASE/ExcerptaMedica, MediaFinder-Standard Periodical Directory, Medline, Scopus, EMBASE, Genamics Journal Seek, PubsHub, and J-Gate.

For details about the latest issues, visit: http://benthamscience.com/journal/index.php?journalID=cdt

 

Current Molecular Imaging, 3 Issue 1

Aims & scope

Current Molecular Imaging publishes peer reviewed expert review articles and special topic issues on all aspects of experimental and clinical research in molecular imaging. Topics include the investigative and practical applications of novel radiopharmaceuticals; standard and complicated imaging methodologies and probes; as well as standard and evolving quantitative approaches.

http://www.eurekaselect.com/124654/issue/1

Abstracted & Indexed in

Chemical Abstracts, J-Gate, PubsHub, and Scopus.

For details about the latest issues, visit: http://benthamscience.com/journal/index.php?journalID=cmi

 

Recent Patents on Anti-Infective Drug Discovery, 9 Issue 1

Aims & scope

Recent Patents on Anti-Infective Drug Discovery publishes review and research articles, drug clinical trial studies and guest edited thematic issues on recent patents in the field of anti-infective drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-infective drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-infective drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-infective drug discovery.

http://www.eurekaselect.com/124637/issue/1

Abstracted & Indexed in

PubMed/Medline, Scopus, EMBASE, METADEX, CAB Abstracts, Cambridge Scientific Abstracts (CSA), Chemical Abstracts, GenamicsJournalSeek, MediaFinder®-Standard Periodical Directory, PubsHub, and J-Gate.

For details about the latest issues, visit:http://benthamscience.com/journal/index.php?journalID=rpaidd

Recent issue of the Journal Current Radiopharmaceuticals has been published

Current Radiopharmaceuticals, 7 Issue 1

http://bit.ly/1onoCeQ

Aims & Scope

Current Radiopharmaceuticals publishes original research articles, letters, reviews, drug clinical trial studies and guest edited issues on all aspects of research and development of radiolabelled compound preparations. The scope of the journal covers the following areas: radio imaging techniques, therapies; preparation and application of radionuclide compounds including the incorporation of tracer methods used in scientific research and applications.

Abstracted & Indexed in:

Chemical Abstracts, Scopus, EMBASE, Media Finder®-Standard Periodical Directory, Genamics Journal Seek, MEDLINE, PubsHub, J-Gate.

For more details please visit: http://bit.ly/1qpUXGN

Bentham Science Launches “Current Microwave Chemistry”

News release date: May 27, 2014

Bentham Science Publishers is proud to announce the launch of a new journal, Current Microwave Chemistry in May 2014. The inaugural journal issue is available online for free access via: http://benthamscience.com/journal/contents.php?journalID=cmic&issueID=122246

The journal covers microwave-assisted synthesis of novel organic, organometallic and inorganic molecules or complexes, kinetics and mechanistic studies of microwave-induced chemical reactions and potential use of microwave irradiation in the fields of drug discovery, green chemistry, catalysis and industrial process development. It is the premier source of microwave related information for chemists, biologists, pharmacologists and engineers in both industry and academia. The journal is available in both electronic and print editions.

For more details on this new journal, visit the website: Current Microwave Chemistry

Broadcast your Podcast

Submit your article in one of our Journals, and get a chance to promote your published research through a Podcast! Bentham Science Publishers will upload a short video clip of you and your research work on their Social Media Forums for FREE! Get instant exposure, maximum audience attention and improved search engine results for your articles published with us.

The links of the authors who have submitted their Podcasts are mentioned below, please feel free to like and suggest to friends.

*Title: Benefits of Fish Oil; Behavior Impairment and Oxidative Stress in Rats Subjected to a Hepatic Encephalopathy Model

Journal: CNS & Neurological Disorders – Drug Targets

Author: Dr. Anete C.Ferraz

Youtube Link: https://www.youtube.com/watch?v=HMOI3dbxFUY

 

* Title: Introduction to Molecular Topology: Basic Concepts and Application to Drug Design

Journal: Current Computer-Aided Drug Design (CCADD)

Author: Dr Jorge Gálvez

Youtube Link: https://www.youtube.com/watch?v=ClWN4lzwhtE

* Title: Investigation of the Mechanism of Protein Denaturation by Guanidine Hydrochloride-Induced Dissociation of Inhibitor-Protease Complexes

Journal: Protein & Peptide Letters

Author: Dr. Mohammad A Qasim

Youtube Link: https://www.youtube.com/watch?v=fWwMhY5eHeE

* Title: A New Binding Site Involving the C-terminal Domain to Design Specific Inhibitors of PepX

Journal: Protein and Peptide Letters

Author: Dr Pascal Rigolet

Youtube Link: https://www.youtube.com/watch?v=wVMNfGY9JUk

* Title: TRP Channels: New Potential Therapeutic Approaches in CNS Neuropathies

Journal: CNS & Neurological Disorders – Drug Targets

Author: Dr Massimo Nabissi

Youtube Link:https://www.youtube.com/watch?v=fvU-Z9hP8MI

Author’s Comments about Bentham Science Publishers!!

• Current Pharmaceutical Analysis

“The publishing procedure at Bentham Science Publishers is fast, efficient and professional. It was a great pleasure for me to publish my work in their journal Current Pharmaceutical Analysis.”

Dr. Ismail Murat Palabiyik
Department of Analytical
Chemistry
Faculty of Pharmacy
University of Ankara
Turkey

• Current Medicinal Chemistry

“Our article was published in the special issue, “Chemistry and Biology of Antioxidants” of Current Medicinal Chemistry at Bentham Science Publishers. Our experience with the Manager Graphics and Senior Manager Publications was very positive. Both of them were not only professional, effective and helpful but also quite pleasant to work with.”

Dr. Iva Bousova, Ph.D.
Dept of Biochemical Sciences
Charles University Prague,
Faculty of Pharmacy
Heyrovskeho
Czech Republic

• Letters in Drug Design & Discovery

“It has been an excellent experience working with Bentham Science Publishers, where the review process is fast and efficient, and the editorial staff is friendly and helpful. Bentham Science is a great place to publish your research paper, and I look forward to working with them further.”

Prof. Dr. Xinyong Liu
Department of Medicinal Chemistry
School of Pharmaceutical Sciences
Shandong University
Shandong, China

• Anti-Cancer Agents in Medicinal Chemistry

“I am glad to have my work published in Anti- Cancer Agents in Medicinal Chemistry. I found the publication process to be professional and efficient. The papers are reviewed rapidly and included promptly to PubMed. I highly recommend scientists to submit their papers at Bentham Science Publishers.”

Dr. Vita M. Golubovskaya
Department of
Surgical Oncology,
Roswell Park Cancer Institute
Buffalo, NY

• Inflammation & Allergy – Drug Targets:

“I began my experience with Bentham Science Publishers by submitting my review article on the website of Inflammation & Allergy – Drug Targets. I found the website easy to use and needed only a few steps to finish my submission.
I received the first reply in a short time afterwards. After addressing the comments, I resubmitted it. I was surprised by the rapid acceptance after only a week and my review was added online on the journal website in a few days. I found the team to be very helpful and responsive.
I would like to keep working with Bentham Science in future as well. I will soon submit another manuscript on my ongoing project in my lab with them. I recommend Bentham Science to my colleagues as well.”

Mohammed Al-Gayyar, PhDAssociate Professor of Clinical Biochemistry
Faculty of Pharmacy University of Mansoura
Egypt

• Drug Delivery Letters

“I appreciate the prompt response by Bentham Science Publisher to my manuscript
submission in Drug Delivery Letters. Speedy processing of articles.
the quality is the hallmark of Bentham Science. I do believe that Drug Delivery Letters
will become a leading journal in the Pharma sector in future.”

• Letters in Organic ChemistryDr. Chinam Niranjan Patra
Department of Pharmaceutics,
Roland Institute of Pharmaceutical Sciences,
Berhampur Odisha,
India

“ I sincerely believe that Bentham Science Publishers is just perfect! I can feel a high
level of commitment and responsibility from their editors. Bentham Science is my first
choice and I would like to recommend it to my friends as well.”

Dr. Jinjun Liu
Institute of Chinese Tranditional Medicine,
Chendde Medical College,
Chengde
China

• Current Drug Targets

“ I had a wonderful experience working with Bentham Science Publishers. I found the
editors to be knowledgeable and quite professional in handling the manuscript. I am glad
to have my research paper in Current Drug Targets to be published timely. Thank you.”

Lei Xie, Ph.D.

Associate Professor

Department of Computer Science,

Hunter College
The City University of New York

Focus On Research With Rakesh Rathore, PhD

One of our respected Editorial Board Members of  Bentham Science journal ‘Combinatorial Chemistry & High Throughput Screening’ , Rakesh Rathore, has contributed to the implementation of mass spectrometry-based high-throughput screening technologies to identify drug leads and made us all very proud of him:

Focus On Research With Rakesh Rathore, PhD

After a receiving his PhD in biochemistry from Govind Ballabh Pant University and his master’s degree from Cancer Hospital & Research Institute, both in India, Rakesh Rathore conducted postdoctoral research in the Department of Biochemistry & Biophysics at Göteborg University in Sweden and then the Center for Cardiovascular Sciences at Albany Medical Center. Rathore is currently working as a research scientist within the Proteomics & Mass Spectrometry Core Laboratory and the Department of Cancer Biology at UC.He is involved in implementing mass spectrometry-based high-throughput screening technologies to identify drug leads. Mass spectrometry is a tool that can be effectively used to detect ionizable elements in a wide variety of sample types in the form of mass to charge ratio. Mass spectrometry-based assays offer a rapid, sensitive and direct approach to measure the effects on enzyme activity.He also oversees the operation of the UC diverse pharmaceutical compound repository, which consists of over 350,000 compounds. He serves as reviewer and editorial advisory board member in drug discovery and development journals, including the Combinatorial Chemistry & High Throughput Screening and the Journal of Bimolecular Screening.What brought you to UC?“I was looking for new technology development opportunities after several years of conducting calcium signaling basic research at Albany Medical Center, and at the same time, my wife assumed a fellowship at a Dayton-based health care system. So we decided to move to this area, where I obtained a research position in the Proteomics & Mass Spectrometry Laboratory with Ken Greis, PhD, on a drug discovery technology project which was funded by MDS Analytical Technologies in Canada. Since industry is currently taking part in many collaborative research efforts with academia, this unique position made my move to UC a great professional opportunity. This area turns out to be a great place to raise a family, and we have been here for about six years.”What is the focus of your research? What discoveries have you made?“My focus of research is on mass spectrometry-based enzyme assay development and high-throughput screening technologies for drug discovery applications, and we have developed a new mass spectrometry-based tool that provides more precise, cost-effective data collection for drug discovery. “Using robotics, data processing and control software, liquid handling devices, and sensitive detectors, high-throughput screening allows a researcher to quickly conduct millions of chemical, genetic or pharmacological tests. Through this process one can rapidly identify active compounds which modulate a particular biomolecular pathway. The results of these experiments provide starting points for drug design and for understanding the interaction or role of a particular biochemical process in biology. “Recently we have extended our capabilities to screen more than 30,000 compounds with mass spectrometry and compared our results with conventional fluorescence methods, which is part of a National Cancer Institute-funded Innovative Molecular Analysis Technologies grant with Dr. Greis. We obtained interesting data to help understand how one can improve the chances of obtaining hits more likely to succeed in clinical trials, which would have been missed using traditional methods of screening. This has the potential of changing the way drug discovery research is performed. “We further extended this technology to develop a fee for service model for other investigators that was demonstrated by 25,000 compounds screened for a group at Case Western Reserve University. Now, we can offer targeted screening of 1,000 to 5,000 compounds as a revenue source for core facility. “This year, the work was recognized as a finalist of the Waters Corporation poster award during the 2013 Association of Biomolecular Resource Facilities conference and in the ‘Gallery Of Excellence’ at UC Research Day 2013. “At UC, I worked on a Global Cardiovascular Innovation Center grant to the company CardioCeption, LLC, founded by Keith Jones, PhD, and part of the UC Tech Accelerator, which was involved in the pre-clinical studies in various cardiovascular conditions.” How will this impact patient care? “Drug discovery is the perfect bridge between basic and clinical research. We are one of very few research institutes to have a library of over 350,000 compounds, which enables us to screen many new and existing drug targets for new leads with the potential for new therapeutics. From our own data using this library, we obtained promising hits and are further evaluating the results, which may have the potential to impact patient care through the development of successful drugs in the future.” What do you like to do in your spare time? “I mainly enjoy spending time with my family and friends and traveling. I have a 3-year-old daughter who loves playing with me, thus my evening time is quite different from what I do at UC. I have been involved with United Way activities in the recent past and would like to continue such services to similar nonprofit organizations.”

Borrowed from http://healthnews.uc.edu/news/?/23525/

Bentham’s Popular, High Impact Titles 2013

Bentham Impact Journals 2013:

Current Gene Therapy 5.318
Current Drug Metabolism 4.405
Current Molecular Medicine 4.197
Current Cancer Drug Targets 4.000
Current Drug Targets 3.848
CNS & Neurological Disorders – Drug Targets 3.769
Current Topics in Medicinal Chemistry 3.702
Current Alzheimer Research 3.676
Current Pharmaceutical Design 3.311
Current Organic Chemistry 3.039
Mini-Reviews in Medicinal Chemistry 2.865
Current Neurovascular Research 2.844
Current Vascular Pharmacology 2.821
Recent Patents on Anti-Cancer Drug Discovery 2.700
Current Pharmaceutical Biotechnology 2.690
Anti-Cancer Agents in Medicinal Chemistry 2.610
Current Genomics 2.475
Current Protein & Peptide Science 2.326
Current HIV Research 2.033
Current Neuropharmacology 2.031
Combinatorial Chemistry & High Throughput Screening 2.000
Protein & Peptide Letters 1.994
Current Analytical Chemistry 1.558
Current Computer-Aided Drug Design 1.540
Medicinal Chemistry 1.373
Current Nanoscience 1.356
Current Pharmaceutical Analysis 1.333
Mini-Reviews in Organic Chemistry 1.063
Current Proteomics 0.828

For more details, please visit http://www.benthamscience.com/

Bentham Impact Titles 2013

 

Our Gratitude for Our Researchers

The success of Bentham Science Publishers is due to our authors, contributors and editors who are a part of the Bentham Team. They are professionals associated with top class universities and research institutions from all over the world, consistently contributing outstanding research articles in our journals and books. Professor Roman Lesyk of Dept. of Pharmaceutical, Organic and Bioorganic Chemistry at Pharmacy Danylo Halytsky Lviv National Medical University, a specialist in the field of organic and medicinal chemistry, commented that he drew great pleasure while working with the staff of Current Topics in Medicinal Chemistry. He especially approved of the professional manner in which the reviewers as well as the editorial board handled the publication process at Bentham Science. The result, he believes is a top notch quality of scientific material presentation.

http://www.benthamscience.com/

Our Rsearchers